242 related articles for article (PubMed ID: 10651061)
1. Pharmacological evidence for both neuronal and smooth muscular PAC1 receptors and a VIP-specific receptor in rat colon.
Ekblad E
Regul Pept; 1999 Dec; 85(2-3):87-92. PubMed ID: 10651061
[TBL] [Abstract][Full Text] [Related]
2. Distinct receptors mediate pituitary adenylate cyclase-activating peptide- and vasoactive intestinal peptide-induced relaxation of rat ileal longitudinal muscle.
Ekblad E; Sundler F
Eur J Pharmacol; 1997 Sep; 334(1):61-6. PubMed ID: 9346329
[TBL] [Abstract][Full Text] [Related]
3. Characterization of intestinal receptors for VIP and PACAP in rat and in PAC1 receptor knockout mouse.
Ekblad E; Jongsma H; Brabet P; Bockaert J; Sundler F
Ann N Y Acad Sci; 2000; 921():137-47. PubMed ID: 11193817
[TBL] [Abstract][Full Text] [Related]
4. Heterogeneity of neuronal and smooth muscle receptors involved in the VIP- and PACAP-induced relaxations of the pig intravesical ureter.
Hernández M; Barahona MV; Recio P; Rivera L; Benedito S; Martínez AC; García-Sacristán A; Orensanz LM; Prieto D
Br J Pharmacol; 2004 Jan; 141(1):123-31. PubMed ID: 14662737
[TBL] [Abstract][Full Text] [Related]
5. VIP- and PACAP-mediated nonadrenergic, noncholinergic inhibition in longitudinal muscle of rat distal colon: involvement of activation of charybdotoxin- and apamin-sensitive K+ channels.
Kishi M; Takeuchi T; Suthamnatpong N; Ishii T; Nishio H; Hata F; Takewaki T
Br J Pharmacol; 1996 Oct; 119(4):623-30. PubMed ID: 8904634
[TBL] [Abstract][Full Text] [Related]
6. Mediators of nonadrenergic, noncholinergic relaxation in longitudinal muscle of the intestine of ICR mice.
Satoh Y; Takeuchi T; Yamazaki Y; Okishio Y; Nishio H; Takatsuji K; Hata F
J Smooth Muscle Res; 1999 Jun; 35(3):65-75. PubMed ID: 10593572
[TBL] [Abstract][Full Text] [Related]
7. Dual effects of PACAP on guinea pig gallbladder muscle via PACAP-preferring and VIP/PACAP-preferring receptors.
Parkman HP; Pagano AP; Ryan JP
Am J Physiol; 1997 Jun; 272(6 Pt 1):G1433-8. PubMed ID: 9227479
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory pathways in the circular muscle of rat jejunum.
Vanneste G; Robberecht P; Lefebvre RA
Br J Pharmacol; 2004 Sep; 143(1):107-18. PubMed ID: 15302684
[TBL] [Abstract][Full Text] [Related]
9. Evidence for roles of vasoactive intestinal polypeptide (VIP) and pituitary adenylate cyclase activating polypeptide (PACAP) receptors in modulating the responses of rat dorsal horn neurons to sensory inputs.
Dickinson T; Fleetwood-Walker SM; Mitchell R; Lutz EM
Neuropeptides; 1997 Apr; 31(2):175-85. PubMed ID: 9179871
[TBL] [Abstract][Full Text] [Related]
10. A cloned frog vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating polypeptide receptor exhibits pharmacological and tissue distribution characteristics of both VPAC1 and VPAC2 receptors in mammals.
Alexandre D; Anouar Y; Jegou S; Fournier A; Vaudry H
Endocrinology; 1999 Mar; 140(3):1285-93. PubMed ID: 10067855
[TBL] [Abstract][Full Text] [Related]
11. Pituitary adenylate cyclase activating polypeptide (PACAP) and vasoactive intestinal peptide (VIP) stimulate interleukin-6 production through the third subtype of PACAP/VIP receptor in rat bone marrow-derived stromal cells.
Cai Y; Xin X; Shim GJ; Mokuno Y; Uehara H; Yamada T; Agui T; Matsumoto K
Endocrinology; 1997 Jun; 138(6):2515-20. PubMed ID: 9165043
[TBL] [Abstract][Full Text] [Related]
12. Characterization of PACAP receptors and signaling pathways in rabbit gastric muscle cells.
Murthy KS; Jin JG; Grider JR; Makhlouf GM
Am J Physiol; 1997 Jun; 272(6 Pt 1):G1391-9. PubMed ID: 9227474
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory transmission in tenia coli mediated by distinct vasoactive intestinal peptide and apamin-sensitive pituitary adenylate cyclase activating peptide receptors.
Jin JG; Katsoulis S; Schmidt WE; Grider JR
J Pharmacol Exp Ther; 1994 Aug; 270(2):433-9. PubMed ID: 8071835
[TBL] [Abstract][Full Text] [Related]
14. Intestinal adaptation in atrophic rat ileum is accompanied by supersensitivity to vasoactive intestinal peptide, pituitary adenylate cyclase-activating peptide and nitric oxide.
Ekelund M; Ekblad E
Scand J Gastroenterol; 2001 Mar; 36(3):251-7. PubMed ID: 11305511
[TBL] [Abstract][Full Text] [Related]
15. Pituitary adenylate cyclase-activating polypeptide and PACAP receptor expression and function in the rat adrenal gland.
Mazzocchi G; Malendowicz LK; Neri G; Andreis PG; Ziolkowska A; Gottardo L; Nowak KW; Nussdorfer GG
Int J Mol Med; 2002 Mar; 9(3):233-43. PubMed ID: 11836629
[TBL] [Abstract][Full Text] [Related]
16. Pituitary adenylate cyclase-activating polypeptide receptors mediating insulin secretion in rodent pancreatic islets are coupled to adenylate cyclase but not to PLC.
Jamen F; Puech R; Bockaert J; Brabet P; Bertrand G
Endocrinology; 2002 Apr; 143(4):1253-9. PubMed ID: 11897681
[TBL] [Abstract][Full Text] [Related]
17. VPAC2-R mediates the lipolytic effects of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide in primary rat adipocytes.
Akesson L; Ahrén B; Edgren G; Degerman E
Endocrinology; 2005 Feb; 146(2):744-50. PubMed ID: 15514088
[TBL] [Abstract][Full Text] [Related]
18. Receptors and transcriptional factors involved in the anti-inflammatory activity of VIP and PACAP.
Leceta J; Gomariz RP; Martinez C; Abad C; Ganea D; Delgado M
Ann N Y Acad Sci; 2000; 921():92-102. PubMed ID: 11193883
[TBL] [Abstract][Full Text] [Related]
19. Maxadilan specifically interacts with PAC1 receptor, which is a dominant form of PACAP/VIP family receptors in cultured rat cortical neurons.
Tatsuno I; Uchida D; Tanaka T; Saeki N; Hirai A; Saito Y; Moro O; Tajima M
Brain Res; 2001 Jan; 889(1-2):138-48. PubMed ID: 11166697
[TBL] [Abstract][Full Text] [Related]
20. Rat aortic smooth-muscle cell proliferation is bidirectionally regulated in a cell cycle-dependent manner via PACAP/VIP type 2 receptor.
Miyata A; Sato K; Hino J; Tamakawa H; Matsuo H; Kangawa K
Ann N Y Acad Sci; 1998 Dec; 865():73-81. PubMed ID: 9927999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]